XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenues:        
Total revenue $ 1,777 $ 2,766 $ 3,232 $ 5,163
Costs and expenses:        
Cost of revenue 515 624 1,021 1,433
Research and development 11,449 8,759 23,033 18,604
General and administrative 5,386 4,752 11,525 11,596
Licensing 1,335 1,285 2,345 2,316
Revaluation of contingent consideration 1,500 200 1,800 3,000
Total costs and expenses 20,185 15,620 39,724 36,949
Loss from operations (18,408) (12,854) (36,492) (31,786)
Other income:        
Interest income 2,018 1,868 4,184 3,859
Non-cash royalty income 961   1,794  
Total other income 2,979 1,868 5,978 3,859
Net loss $ (15,429) $ (10,986) $ (30,514) $ (27,927)
Net loss per share, basic $ (0.13) $ (0.15) $ (0.25) $ (0.39)
Net loss per share, diluted $ (0.13) $ (0.15) $ (0.25) $ (0.39)
Weighted average common shares outstanding, basic 122,580,967 71,291,400 122,486,162 71,183,129
Weighted average common shares outstanding, diluted 122,580,967 71,291,400 122,486,162 71,183,129
Other comprehensive income:        
Unrealized gain (loss) on marketable securities, net of tax of $0 $ 48 $ (99) $ 385 $ (357)
Total other comprehensive income (loss) 48 (99) 385 (357)
Comprehensive loss (15,381) (11,085) (30,129) (28,284)
Contract research        
Revenues:        
Total revenue 442 625 887 1,281
Licensing        
Revenues:        
Total revenue $ 1,335 $ 2,141 $ 2,345 $ 3,882